Clinical Trial

Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2022 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-04-15; most recent amendment 2022-03-14.
Trial Details
NCT Number NCT02744365
Lead Sponsor CHU de Quebec-Universite Laval
Conditions Preeclampsia, Preterm Birth, Pregnancy Complications, Fetal Anomalies
Enrollment 7,845 participants
Start Date 2015-04
Primary Completion 2025-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2022-03-16